BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4067096)

  • 1. Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force III: Hypertrophic cardiomyopathy, other myopericardial diseases and mitral valve prolapse.
    Maron BJ; Gaffney FA; Jeresaty RM; McKenna WJ; Miller WW
    J Am Coll Cardiol; 1985 Dec; 6(6):1215-7. PubMed ID: 4067096
    [No Abstract]   [Full Text] [Related]  

  • 2. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse.
    Maron BJ; Isner JM; McKenna WJ
    Med Sci Sports Exerc; 1994 Oct; 26(10 Suppl):S261-7. PubMed ID: 7934749
    [No Abstract]   [Full Text] [Related]  

  • 3. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse.
    Maron BJ; Isner JM; McKenna WJ
    J Am Coll Cardiol; 1994 Oct; 24(4):880-5. PubMed ID: 7930220
    [No Abstract]   [Full Text] [Related]  

  • 4. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome.
    Maron BJ; Ackerman MJ; Nishimura RA; Pyeritz RE; Towbin JA; Udelson JE
    J Am Coll Cardiol; 2005 Apr; 45(8):1340-5. PubMed ID: 15837284
    [No Abstract]   [Full Text] [Related]  

  • 5. Phonoechocardiographic identification of chordal snap in hypertrophic cardiomyopathy.
    Kawazoe Y; Otsuji Y; Kisanuki A; Tanaka H
    Intern Med; 1992 Sep; 31(9):1094-7. PubMed ID: 1421715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expiratory increase in the LV outflow obstruction in IHSS.
    Reddy CV; Gould L; Singh BK; Zen B
    Cathet Cardiovasc Diagn; 1980; 6(3):349-50. PubMed ID: 7192605
    [No Abstract]   [Full Text] [Related]  

  • 7. [Holosystolic mitral valve prolapse and "SAM" after surgical treatment of hypertrophic obstructive cardiomyopathy (author's transl)].
    Böcker K; Köhler E; Kuhn H; Körfer R
    Z Kardiol; 1981 May; 70(5):403-5. PubMed ID: 7196657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitral valve prolapse and hypertrophic cardiomyopathy in a pup.
    Swindle MM; Huber AC; Kan JS; Starr FL; Samphilipo MA
    J Am Vet Med Assoc; 1984 Jun; 184(12):1515-7. PubMed ID: 6539766
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular evaluation of the young athlete.
    Strong WB; Steed D
    Pediatr Clin North Am; 1982 Dec; 29(6):1325-39. PubMed ID: 7177724
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitral valve prolapse and idiopathic hypertrophic subaortic stenosis: two sources of chest pain in young adults.
    Oertel T; Love M
    J Emerg Nurs; 1983; 9(1):21-6. PubMed ID: 6338276
    [No Abstract]   [Full Text] [Related]  

  • 11. [Echocardiographic data in heterotrophic and congestive cardiomyopathies].
    Smith ER
    Union Med Can; 1977 Feb; 106(2):187-90. PubMed ID: 557855
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy mimicking pericardial constriction or myocardial restriction.
    Waller BF; Maron BJ; Morrow AG; Roberts WC
    Am Heart J; 1981 Oct; 102(4):790-2. PubMed ID: 7197115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mitral valve prolapse].
    Storozhakov GI; Vereshchagina GS
    Kardiologiia; 1990 Dec; 30(12):88-93. PubMed ID: 2097412
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary versus secondary mitral valve prolapse: clinical features and implications.
    Levine HJ; Isner JM; Salem DN
    Clin Cardiol; 1982 Jun; 5(6):371-5. PubMed ID: 7049478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular evaluation of adolescents and young adults. Salient aspects of the examination.
    Goldfield N; Neinstein L; Wohlgelernter D
    Postgrad Med; 1986 Apr; 79(5):111-9. PubMed ID: 3960794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Udelson JE; Bonow RO; Nishimura RA; Ackerman MJ; Estes NA; Cooper LT; Link MS; Maron MS;
    Circulation; 2015 Dec; 132(22):e273-80. PubMed ID: 26621644
    [No Abstract]   [Full Text] [Related]  

  • 17. Systolic anterior motion of mitral valve with calcified annulus in octogenarians.
    Parissis H; Hamid UI; Jeganathan R; Graham A
    Asian Cardiovasc Thorac Ann; 2013 Aug; 21(4):456-9. PubMed ID: 24570531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of electrophysiologic testing in managing patients who have ventricular tachycardia unrelated to coronary artery disease.
    Naccarelli GV; Prystowsky EN; Jackman WM; Heger JJ; Rahilly GT; Zipes DP
    Am J Cardiol; 1982 Jul; 50(1):165-71. PubMed ID: 7201234
    [No Abstract]   [Full Text] [Related]  

  • 19. [The value of M-mode echocardiography in children].
    Schmaltz AA
    Fortschr Med; 1980 Jun; 98(22):862-4. PubMed ID: 7190955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical applications of echocardiography in myocardial and valvular heart disease.
    Belkin RN; Kisslo J
    Prog Cardiovasc Dis; 1986; 29(2):81-106. PubMed ID: 2945227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.